Prospective evaluation of Konjac Glucomannan Gel as Conducting Medium for Miniprobe Endoscopic Ultrasound

Feasibility study of Konjac Glucomannan Gel as Conducting Medium for Miniprobe Endoscopic Ultrasound

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400090266

Enrollment

Unknown

Registered

2024-09-26

Start date

2024-10-01

Completion date

Unknown

Last updated

2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Konjac Glucomannan Gel Group:Using Konjac Glucomannan Gel as Conducting Medium for Miniprobe Endoscopic Ultrasound

De-aerated Water:Using De-aerated Water as Conducting Medium for Miniprobe Endoscopic Ultrasound

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion Criteria for Healthy Volunteers (1) Age 18-75 years (2) No symptoms of digestive discomfort such as nausea, vomiting, acid reflux, bloating, abdominal pain, or diarrhea within the past year (3) No history of allergy to polyglucosamine (4) Able to tolerate general anesthesia (5) Signed informed consent 2. Inclusion Criteria for Mucosal Lesion Group (1) Age 18-75 years (2)Diagnosed with esophageal or gastric mucosal lesions via endoscopy (3) No symptoms of digestive discomfort such as nausea, vomiting, acid reflux, bloating, abdominal pain, or diarrhea within the past year (4) No history of allergy to polyglucosamine (5) Able to tolerate general anesthesia (6) Signed informed consent 3. Inclusion Criteria for Submucosal Lesion Group (1) Age 18-75 years (2) Diagnosed with gastrointestinal submucosal tumors (SMT) and scheduled for an endoscopic ultrasound (EUS) examination (3) No symptoms of digestive discomfort such as nausea, vomiting, acid reflux, bloating, abdominal pain, or diarrhea within the past year (4) No history of allergy to polyglucosamine (5) Able to tolerate general anesthesia (6) Signed informed consent

Exclusion criteria

Exclusion criteria: (1) Pregnancy (2) Subject refusal (3) Subjects unable to cooperate with the examination for any reason (4) History of inflammatory bowel disease or intestinal obstruction (5) Patients who have used anticoagulants within the past week or have coagulation disorders (6) Patients deemed unsuitable for inclusion in the study by the researcher for any other reason

Design outcomes

Primary

Measure	Time frame
Image Quality;	—

Countries

China

Contacts

Public ContactDuanmin Hu

Second Affiliated Hospital of Soochow University

duanminhu@163.com+86 189 1314 1923

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026